Image

Describe to Better Understand, the Mealtime of People With Parkinson's Disease Dependent on Food Intake

Recruiting
years of age
Both
Phase N/A

Powered by AI

Overview

The main objective is to describe strategies (verbal, non-verbal (gesture, intonation), and environmental), designed and used by the assisting/aided dyad to feed a dysphagic dependent person by articulating the safe and hedonic dimensions in the context of Parkinson's disease or atypical parkinsonian syndrome during a meal

Description

It is described in the literature that being helped for the meal disrupts the pre-oral phase in the visual and proprioceptive afferences received by the sick person to prepare neurologically the other phases of swallowing. In cases of dysphagia, regardless of the cause, the need for food assistance is correlated with higher mortality and an increased risk of pneumonia. Thus, whether at home or in an establishment, human help is often put in place to facilitate the time of the meal, make it more effective (limitation of the duration of the meal, maximization of the nutritional amounts ingested) and safe (prevention of the occurrence of wrong driving). Our hypothesis is that representations about food and aid at meal times, as well as the attitudes of both the helper and the helped, are factors influencing the realization of an adapted human aid when eating a meal in a dependent person. An observation of a meal during a hospitalization and an interview with the sick person and his caregiver are carried out independently. Between 15 days and a month after the first visit, excerpts from the film will be presented and commented by the dyad according to the technique of self-confrontation. A report of the thematic elements identified during the interviews will be proposed for validation by the dyad. This visit can be made during a scheduled appointment in the hospital, by videoconference or at home if the participants do not have access to a videoconference system.

Eligibility

For patients:

Inclusion Criteria:

  • Patient with typical or atypical Parkinsonian syndrome, collected in the medical record
  • Indication of swallowing disorders or dysphagia, according to item 2.3 chewing and swallowing, part II of the Movement Disorder Society - Unified Parkinson's Disease Rating Scale (MDS-UPDRS) scale or collection in the medical record
  • Person dependent on food (according to MDS-UPDRS - food tasks item, part II, 2.4, need help with all food tasks)
  • Day or traditional hospitalization in the neurology department, including a meal.
  • Having a usual caregiver present for the meal.
  • Affiliated person or beneficiary of a social security scheme.
  • Free, informed, written and signed consent by participant and investigator (no later than the day of inclusion and prior to any review required by the research)

Exclusion Criteria:

  • Individuals whose cognitive state does not allow simple questions to be answered, as judged by the neurologist
  • Person fed exclusively by enteral nutrition.
  • Patient who refuses to be filmed

For caregivers:

Inclusion Criteria:

  • caregiver of the patient for at least 2 months for the taking of meal
  • Person with French language to answer the questions of the interview

Exclusion Criteria:

  • Patient who refuses to be filmed
  • Protected patient: under guardianship, trusteeship or other legal protection, deprived of freedom by judicial or administrative decision

Study details

Parkinson Disease, Deglutition Disorders

NCT05898139

University Hospital, Toulouse

16 May 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.